As one of the pioneers of the vaccine industry in Turkey, Keymen needs no introduction. Keymen has always taken a principled and innovative approach to advocating the significance of vaccines in the delivery an effective national health strategy. Over the last 40 years, Keymen has created access to over 13 essential vaccines and supplied over 700 million doses through the public and private sector.
Techinvention, India’s leading vaccine ecosystem brain trust works with customers, partners, regulators and governments using innovative approaches to bring biological and biotech products to the developing world. The team has a number of global firsts to their credit; including enabling the manufacture of polysaccharide conjugate vaccine in Russia; the first hi-tech state-of-the-art vaccine manufacturing facility in Central America; the first access to a specific vaccine from the developing world to Saudi Arabia to ensure continued public program immunisation.
Techinvention, India’s leading vaccine ecosystem brain trust works with customers, partners, regulators and governments using innovative approaches to bring biological and biotech products to the developing world. The team has a number of global firsts to their credit; including enabling the manufacture of polysaccharide conjugate vaccine in Russia; the first hi-tech state-of-the-art vaccine manufacturing facility in Central America; the first access to a specific vaccine from the developing world to Saudi Arabia to ensure continued public program immunisation.
The imperative for an evolving vaccine discourse
Vaccines are one of the most effective public health interventions available, not only in the prevention of illness but also disability and death from treatable and preventable diseases. A 2016 Johns Hopkins University study found that vaccines could save governments $44 dollars for every dollar spent on vaccine.
KeyTech-Bio Pharma is committed to leveraging the expertise of our principals to deliver access to affordable and acceptable vaccines that addresses the unique needs of the Turkish people and our neighbours. We believe that in in contributing to the building of a robust vaccine strategy, we can help Turkey chart a bold new path to healthcare independence.